SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Wang JF) "

Sökning: WFRF:(Wang JF)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  • Clark, DW, et al. (författare)
  • Associations of autozygosity with a broad range of human phenotypes
  • 2019
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10:1, s. 4957-
  • Tidskriftsartikel (refereegranskat)abstract
    • In many species, the offspring of related parents suffer reduced reproductive success, a phenomenon known as inbreeding depression. In humans, the importance of this effect has remained unclear, partly because reproduction between close relatives is both rare and frequently associated with confounding social factors. Here, using genomic inbreeding coefficients (FROH) for >1.4 million individuals, we show that FROH is significantly associated (p < 0.0005) with apparently deleterious changes in 32 out of 100 traits analysed. These changes are associated with runs of homozygosity (ROH), but not with common variant homozygosity, suggesting that genetic variants associated with inbreeding depression are predominantly rare. The effect on fertility is striking: FROH equivalent to the offspring of first cousins is associated with a 55% decrease [95% CI 44–66%] in the odds of having children. Finally, the effects of FROH are confirmed within full-sibling pairs, where the variation in FROH is independent of all environmental confounding.
  •  
32.
  •  
33.
  •  
34.
  •  
35.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
36.
  •  
37.
  •  
38.
  •  
39.
  •  
40.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (227)
konferensbidrag (9)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (201)
övrigt vetenskapligt/konstnärligt (36)
Författare/redaktör
Jonas, JB (38)
Hayward, C. (38)
Gudnason, V (37)
Ikram, MA (37)
Brenner, H (35)
Metspalu, A (35)
visa fler...
Peters, A (32)
Wilson, JF (32)
Gieger, C (32)
Psaty, BM (31)
Lehtimaki, T. (31)
Boerwinkle, E (30)
Uitterlinden, AG (29)
Snieder, H. (29)
Esko, T (29)
Polašek, O. (29)
Gupta, R. (28)
Martin, NG (28)
Salomaa, V (27)
Mahajan, A. (26)
Wong, TY (26)
Stefansson, K (26)
Rudan, I. (26)
Hottenga, JJ (25)
Smith, AV (25)
Campbell, A (25)
Boomsma, DI (24)
van Duijn, CM (24)
Cheng, CY (24)
Vollenweider, P. (24)
Kraft, P (24)
Campbell, H (24)
Farzadfar, F (23)
Kim, YJ (23)
Yang, J. (23)
Lind, L (23)
Wareham, NJ (23)
Li, Y. (22)
Zheng, W. (22)
Khader, YS (22)
Malekzadeh, R (22)
Hofman, A (22)
Rotter, JI (22)
Amin, N (21)
Wang, Q. (21)
Teumer, A (21)
Volzke, H (21)
Chanock, SJ (21)
Khaw, KT (21)
Zhao, JH (21)
visa färre...
Lärosäte
Karolinska Institutet (231)
Uppsala universitet (61)
Lunds universitet (44)
Göteborgs universitet (27)
Umeå universitet (24)
Högskolan Dalarna (16)
visa fler...
Stockholms universitet (7)
Högskolan i Skövde (5)
Örebro universitet (4)
Kungliga Tekniska Högskolan (3)
Linköpings universitet (3)
Jönköping University (3)
Handelshögskolan i Stockholm (2)
Södertörns högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (240)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (93)
Naturvetenskap (9)
Samhällsvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy